Nisa Investment Advisors, LLC Syros Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$1.02 - $3.8 $7,405 - $27,588	-7,260 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$3.26 - $4.66 $23,667 - $33,831	7,260 New	7,260 $14,000
Q2 2021 Aug 06, 2021	SELL	$5.01 - $7.48 $65,130 - $97,240	-13,000 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$6.66 - $14.66 $86,580 - $190,580	13,000 New	13,000 $141,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.